How Rx1 and Pax6 Affect Amacrine Cell Types in Xenopus
Author Information
Author(s): Norann A. Zaghloul, Sally A. Moody
Primary Institution: The George Washington University
Hypothesis
Altering Rx1 or Pax6 activity during eye field stages affects the production of three neurotransmitter subtypes of amacrine cells.
Conclusion
Rx1 and Pax6 differentially modify the ability of eye field precursors to produce different neurotransmitter subtypes of amacrine cells.
Supporting Evidence
- Increasing Rx1 at early stages promotes NPY amacrine cells and represses GABA and DA amacrine cells.
- Increasing Pax6 at early stages represses NPY and DA amacrine cells but does not affect GABA.
- Effects of Rx1 and Pax6 on amacrine cell production are time-dependent.
Takeaway
This study shows that two important genes, Rx1 and Pax6, help decide what types of nerve cells are made in the eye, and they do this differently depending on when they are active.
Methodology
Gain-of-function and loss-of-function hormone-inducible constructs of Rx1 and Pax6 were used to alter protein levels in Xenopus embryos, followed by immunofluorescence histology to count amacrine cell subtypes.
Limitations
The study primarily focuses on specific neurotransmitter subtypes and may not encompass all aspects of retinal development.
Participant Demographics
Xenopus laevis embryos were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website